193 related articles for article (PubMed ID: 35416188)
1. The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies.
Hu T; Yue J; Tang Q; Cheng KW; Chen F; Peng M; Zhou Q; Wang M
Food Funct; 2022 May; 13(9):4789-4803. PubMed ID: 35416188
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence.
Chen XM; Lin GX; Wang X; Ma HY; Wang RS; Wang SM; Tang D
J Ethnopharmacol; 2023 Feb; 302(Pt A):115860. PubMed ID: 36341813
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evidence of the effect of quercetin on diabetic nephropathy: A meta-analysis of animal studies.
Feng X; Bu F; Huang L; Xu W; Wang W; Wu Q
Eur J Pharmacol; 2022 Apr; 921():174868. PubMed ID: 35248552
[TBL] [Abstract][Full Text] [Related]
4. Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: A systematic review and meta-analysis of rodent data.
Li Z; Deng H; Guo X; Yan S; Lu C; Zhao Z; Feng X; Li Q; Wang J; Zeng J; Ma X
Phytomedicine; 2022 Oct; 105():154348. PubMed ID: 35908521
[TBL] [Abstract][Full Text] [Related]
5. The potential therapeutic effects of Trifolium alexandrinum extract, hesperetin and quercetin against diabetic nephropathy via attenuation of oxidative stress, inflammation, GSK-3β and apoptosis in male rats.
Abdou HM; Abd Elkader HAE
Chem Biol Interact; 2022 Jan; 352():109781. PubMed ID: 34922902
[TBL] [Abstract][Full Text] [Related]
6. Ponicidin attenuates streptozotocin-induced diabetic nephropathy in rats via modulating hyperlipidemia, oxidative stress, and inflammatory markers.
An S; Li Y; Jia X; Yang Y; Jia X; Jia X; Xue W
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22988. PubMed ID: 35187780
[TBL] [Abstract][Full Text] [Related]
7. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):244-8. PubMed ID: 15053821
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.
Hu HC; Lei YH; Zhang WH; Luo XQ
Front Pharmacol; 2022; 13():841818. PubMed ID: 35355720
[No Abstract] [Full Text] [Related]
9. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
Song Y; Liu W; Tang K; Zang J; Li D; Gao H
J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
[TBL] [Abstract][Full Text] [Related]
10. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action.
Hu S; Wang J; Liu E; Zhang X; Xiang J; Li W; Wei P; Zeng J; Zhang Y; Ma X
Pharmacol Res; 2022 Nov; 185():106481. PubMed ID: 36195307
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
14. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
15. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
Food Chem Toxicol; 2014 Jan; 63():111-8. PubMed ID: 24211521
[TBL] [Abstract][Full Text] [Related]
16. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
17. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
[TBL] [Abstract][Full Text] [Related]
18. Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.
Luo Q; Cai Y; Zhao Q; Jiang Y; Tian L; Liu Y; Liu WJ
J Diabetes Res; 2022; 2022():3770417. PubMed ID: 35746917
[TBL] [Abstract][Full Text] [Related]
19. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
Maheshwari RA; Balaraman R; Sen AK; Seth AK
Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
[TBL] [Abstract][Full Text] [Related]
20. Galangin protects against oxidative damage and attenuates inflammation and apoptosis via modulation of NF-κB p65 and caspase-3 signaling molecules in a rat model of diabetic nephropathy.
Aladaileh SH; Al-Swailmi FK; Abukhalil MH; Shalayel MH
J Physiol Pharmacol; 2021 Feb; 72(1):. PubMed ID: 34099583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]